PROSTATE SPECIFIC ANTIGEN IMMUNOHISTOCHEMICAL ANTI

Acid Phosphatase (prostatic), Tartrate Inhibited

BAXTER HEALTHCARE CORP.

The following data is part of a premarket notification filed by Baxter Healthcare Corp. with the FDA for Prostate Specific Antigen Immunohistochemical Anti.

Pre-market Notification Details

Device IDK893508
510k NumberK893508
Device Name:PROSTATE SPECIFIC ANTIGEN IMMUNOHISTOCHEMICAL ANTI
ClassificationAcid Phosphatase (prostatic), Tartrate Inhibited
Applicant BAXTER HEALTHCARE CORP. P.O. BOX 3093 Bellevue,  WA  98009
ContactJ Norwood
CorrespondentJ Norwood
BAXTER HEALTHCARE CORP. P.O. BOX 3093 Bellevue,  WA  98009
Product CodeJFH  
CFR Regulation Number862.1020 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1989-05-05
Decision Date1989-08-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.